Village Farms Is Undervalued As International Cannabis Revenue Hits Record Levels
Village Farms International’s Q2 showed record international cannabis sales, facility expansion, cost cuts & a strong balance sheet. Read more about VFF stock.
Canopy Growth: Penny stock purgatory — or cannabis rebound in the making?
The turnaround is becoming more believable.
Top Cannabis Stocks to Watch: What’s Ahead for Canopy Growth (NASDAQ:CGC)?
Cannabis Stocks coverage examines sector conditions, operating developments, competitive dynamics, and broader market context surrounding a listed business.
Trulieve Cannabis: First NYSE-Listed Cannabis Stock Is A Buy
Trulieve Cannabis is the first U.S. cannabis operator to uplist to the NYSE, unlocking broader investor access and liquidity. Read why TRLV stock is a Buy.
Cronos Group: This Cannabis Name Isn’t Reliant On U.S. Legalization Efforts
Cronos Group’s Q2 2026 earnings met bullish expectations, reinforcing its growth thesis and investor confidence. Click here to read my latest analysis.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Trulieve Cannabis: First NYSE-Listed Cannabis Stock Is A Buy
Trulieve Cannabis is the first U.S. cannabis operator to uplist to the NYSE, unlocking broader investor access and liquidity. Read why TRLV stock is a Buy.
Cronos Group: This Cannabis Name Isn’t Reliant On U.S. Legalization Efforts
Cronos Group’s Q2 2026 earnings met bullish expectations, reinforcing its growth thesis and investor confidence. Click here to read my latest analysis.
Aurora Cannabis Q1 Preview: What to expect
Aurora Cannabis ( ACB) is due to report first-quarter earnings on August 5, with analysts’ consensus pointing towards another loss-making quarter. The marijuana producer is projected to report a loss …
Why Is Canopy Growth (NASDAQ:CGC) Leading Cannabis Stock Discussion?
Canopy Growth (CGC) leads a fresh US cannabis stocks review as earnings, peers and macro signals reshape the market debate.
SNDL Q2 Earnings Call Highlights
SNDL (NASDAQ:SNDL) reported lower second-quarter revenue and gross profit as demand weakness across liquor and cannabis markets, cannabis-production ramp-up costs and promotional activity weighed on …
Cannabis Was Ready For Wall St., But Was Wall St. Ready For Cannabis?
Trulieve and Glass House’s NYSE uplistings mark a milestone, but experts warn of investor education gaps, geographic complexity, and a five-year capital drought.
Is Jazz still the best cannabis stock after federal rescheduling?
Jazz Pharmaceuticals JAZZ is best known for its market-leading oxybate franchise, but the company has also carved out a unique position in cannabinoid-based medicine. It markets Epidiolex, the first …
Tilray Brands (NASDAQ:TLRY) Deepens Its Medical Cannabis Reach
Tilray Brands advances international medical cannabis access while regulatory progress, beverages, wellness brands, and operational discipline shape its evolving business outlook.
Should you buy Tilray Brands stock before July 28?
Tilray will release its year-end numbers next week, which could have a significant impact on the stock.
Recent Comments